Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
Gallium Citrate GA 67 is a radioactive diagnostic imaging agent administered by injection to detect certain infections and malignancies. It functions as a radiopharmaceutical that localizes to areas of infection, inflammation, and tumor activity, enabling visualization via nuclear medicine imaging. The product is used primarily in diagnostic nuclear medicine settings to support clinical decision-making.
Late-stage product with modest competitive pressure (30%) and minimal linked career opportunities, signaling a mature, specialized diagnostic niche with limited team expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Gallium Citrate GA 67 offers career exposure to nuclear medicine and diagnostic imaging, a specialized therapeutic area with stable clinical demand. However, the absence of linked job postings and approaching LOE indicate limited growth trajectory and team expansion potential.
Worked on GALLIUM CITRATE GA 67 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.